Richard Sloan

发表

Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load

M. Wainberg, S. Colby-Germinario, Victor G. Kramer, 2012, Antimicrobial Agents and Chemotherapy.

Specific Redistribution Effect that Results in Increased

M. Wainberg, Victor G. Kramer, Maureen Oliveira, 2012 .

Latent HIV-1 Can Be Reactivated by Cellular Superinfection in a Tat-Dependent Manner, Which Can Lead to the Emergence of Multidrug-Resistant Recombinant Viruses

M. Wainberg, D. Donahue, Richard Sloan, 2013, Journal of Virology.

Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.

M. Wainberg, C. Liang, D. Donahue, 2011, Virology.

Tetherin restricts direct cell-to-cell infection of HIV-1

M. Wainberg, C. Liang, T. Bar-Magen, 2010, Retrovirology.

Resistance Substitutions in HIV-1 Integrase G118R-Linked Dolutegravir Drug Biochemical Analysis of the Role of

M. Wainberg, P. Quashie, Nathan Osman, 2014 .

The Role of IFITM Proteins in Tick-Borne Encephalitis Virus Infection

B. Vojtesek, T. Hupp, K. Ball, 2021, Journal of virology.

Transcription of Preintegrated HIV-1 cDNA Modulates Cell Surface Expression of Major Histocompatibility Complex Class I via Nef

M. Wainberg, T. Bar-Magen, Andrew T Roland, 2011, Journal of Virology.

IFITM proteins inhibit HIV-1 protein synthesis

W. Lee, C. Liang, Richard Sloan, 2017, Scientific Reports.

Dynamin-Dependent Endocytosis Cell-to-Cell Transmission via Productive Entry of HIV-1 during

M. Wainberg, D. Donahue, Richard Sloan, 2014 .

Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis

M. Wainberg, J. Münch, T. Mesplède, 2013, Journal of Virology.

Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase

M. Wainberg, P. Quashie, Tamar Veres, 2013, Antimicrobial Agents and Chemotherapy.

HIV-1 Subtype Variability in Vif Derived from Molecular Clones Affects APOBEC3G-Mediated Host Restriction

M. Wainberg, Maureen Oliveira, Susan M. Schader, 2013, Intervirology.

Antiviral Resistance Mutations Potentiate hepatitis B virus Immune Evasion through Disruption of its Surface Antigen a Determinant

R. Tedder, P. Moore, C. Teo, 2008, Antiviral therapy.

IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity

Richard Sloan, Jordan Taylor, Maria Gómez-Herranz, 2022, The Journal of biological chemistry.

Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase Inhibitor

Hongtao Xu, D. Hazuda, M. Wainberg, 2010, Journal of Virology.

Proceedings of the Frontiers of Retrovirology Conference 2016

R. König, D. Elleder, R. Sachidanandam, 2016, Retrovirology.

Novel therapeutic strategies targeting HIV integrase

M. Wainberg, P. Quashie, Richard Sloan, 2012, BMC Medicine.

The role of unintegrated DNA in HIV infection

M. Wainberg, Richard Sloan, 2011, Retrovirology.

Genotyping of acute HBV isolates from England, 1997-2001.

M. Ramsay, C. Teo, Richard Sloan, 2009, Journal of Clinical Virology.

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors

M. Wainberg, C. Tremblay, Eugene L. Asahchop, 2012, Antimicrobial Agents and Chemotherapy.

Neither ritonavir nor darunavir affect cell surface expression of tetherin or Vpu-mediated tetherin down-modulation.

M. Wainberg, C. Liang, T. Bar-Magen, 2010, AIDS.

Phosphatase PP2A is essential for TH17 differentiation

Xiang Gao, Linrong Lu, D. Rohila, 2018, Proceedings of the National Academy of Sciences.

Multidrug-Resistant Recombinant Viruses Which Can Lead to the Emergence of Superinfection in a Tat-Dependent Manner, Latent HIV-1 Can Be Reactivated by Cellular

M. Wainberg, D. Donahue, Richard Sloan, 2014 .

RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction

Christopher E. Jones, K. Marno, Á. McKnight, 2017, Journal of Virology.

Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines

M. Wainberg, Yingshan Han, Victor G. Kramer, 2014, Virology Journal.

IFITM proteins inhibit HIV-1 protein synthesis

W. Lee, C. Liang, Richard Sloan, 2017, bioRxiv.

Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase

M. Wainberg, P. Quashie, Tamar Veres, 2014, Antimicrobial Agents and Chemotherapy.

The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency

M. Wainberg, D. Donahue, Richard Sloan, 2012, Journal of Virology.

and Establishment of HIV-1 Latency The Viral Protein Tat Can Inhibit the

D. Donahue, Richard Sloan, B. Kuhl, 2012 .

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency

M. Wainberg, T. Mesplède, D. Donahue, 2014, Viruses.

HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity

Christopher E. Jones, W. Lee, Paul A. Rowley, 2018, Journal of Virology.

HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays

M. Wainberg, Hong-tao Xu, T. Bar-Magen, 2010, AIDS.

The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism

M. Wainberg, C. Liang, J. Wilkinson, 2011, PloS one.

Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines

M. Wainberg, Yingshan Han, Victor G. Kramer, 2014, Virology Journal.

Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes

M. Wainberg, Hong-tao Xu, T. Bar-Magen, 2009, Retrovirology.

Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes

M. Wainberg, T. Bar-Magen, D. Donahue, 2010, Retrovirology.

Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture

M. Wainberg, T. Bar-Magen, Susan M. Schader, 2009, Antimicrobial Agents and Chemotherapy.

At the forefront of retrovirology research: Frontiers of Retrovirology

M. Wainberg, T. Bar-Magen, Richard Sloan, 2010 .

Proceedings of the Frontiers of Retrovirology Conference 2016

Sebastian A. Wagner, R. König, D. Elleder, 2016, Retrovirology.

Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages

D. Neculai, Linrong Lu, Xuai Lin, 2021, Cellular & Molecular Immunology.

Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse 1

M. Wainberg, Richard Sloan, L. Cécile, 2012 .

Novel therapeutic strategies targeting HIV integrase

M. Wainberg, P. Quashie, Richard Sloan, 2012, BMC Medicine.

Feline immunodeficiency virus env gene evolution in experimentally infected cats.

R. Biek, D. Klein, B. Willett, 2010, Veterinary immunology and immunopathology.

Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load

M. Wainberg, S. Colby-Germinario, Victor G. Kramer, 2012, Antimicrobial Agents and Chemotherapy.

Harnessing the therapeutic potential of host antiviral restriction factors that target HIV

M. Wainberg, Richard Sloan, 2013, Expert review of anti-infective therapy.